Phase I Study of Cellular Adoptive Immunotherapy Using Genetically Modified CD8+ HIV-Specific T Cells for HIV Seropositive Patients Undergoing Allogeneic Bone Marrow Transplant. Fred Hutchinson Cancer Research Center and the University of Washington
- 1 June 1992
- journal article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 3 (3), 319-338
- https://doi.org/10.1089/hum.1992.3.3-319